TY - JOUR
AU - Hannah R. Tierney
AU - Sarah W. Takimoto
AU - Soraya Azari
AU - Scott Steiger
AU - Marlene Martin
A1 - 
AD - School of Medicine, University of California, San Francisco, CA, US Hannah.tierney@ucsf.edu; Department of Medicine, University of California, Los Angeles, CA, US ; Department of Medicine, University of California, San Francisco General Hospital, San Francisco, CA, US ; Tierney, Hannah R.,MPH, 513 Parnassus Ave., Suite S-245,San Francisco,US,94143-0454,School of Medicine, University of California,Hannah.tierney@ucsf.edu
BT - Substance Use & Misuse
C5 - Opioids & Substance Use
CP - 9
DB - APA PsycInfo®
DO - 10.1080/10826084.2023.2212070
IS - 9
JF - Substance Use & Misuse
LA - English
PY - 2023
SN - 1082-6084, 1082-6084
SP - 1172
EP - 1176+
ST - Predictors of linkage to an opioid treatment program and methadone treatment retention following hospital discharge in a safety-net setting
T1 - Predictors of linkage to an opioid treatment program and methadone treatment retention following hospital discharge in a safety-net setting
T2 - Substance Use & Misuse
TI - Predictors of linkage to an opioid treatment program and methadone treatment retention following hospital discharge in a safety-net setting
U1 - Opioids & Substance Use
U3 - 10.1080/10826084.2023.2212070
VL - 58
VO - 1082-6084, 1082-6084
Y1 - 2023
ER -